期刊
BLOOD
卷 101, 期 6, 页码 2099-2114出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2002-07-2314
关键词
-
类别
资金
- NHLBI NIH HHS [HL53586] Funding Source: Medline
Recent conceptual and technical improvements have resulted in clinically meaningful levels of gene transfer into repopulating hematopoietic stem cells. At the same time, evidence is accumulating that gene therapy may induce several kinds of unexpected side effects, based on preclinical and clinical data. To assess the therapeutic potential of genetic interventions in hematopoietic cells, it will be important to derive a classification of side effects, to obtain insights into their underlying mechanisms, and to use rigorous statistical approaches in comparing data. We here review side effects related to target cell manipulation; vector production; transgene insertion and expression; selection procedures for transgenic cells; and immune surveillance. We also address some inherent differences between hematopoiesis in the most commonly used animal model, the laboratory mouse, and in humans. It is our intention to emphasize the need for a critical and hypothesis-driven analysis of transgene toxicology, in order to improve safety, efficiency, and prognosis for the yet small but expanding group of patients that could benefit from gene therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据